Results 71 to 80 of about 15,945 (274)

Risk of Esophageal Adenocarcinoma Decreases With Height, Based on Consortium Analysis and Confirmed by Mendelian Randomization [PDF]

, 2014
Background & Aims Risks for some cancers increase with height. We investigated the relationship between height and risk of esophageal adenocarcinoma (EAC) and its precursor, Barrett's esophagus (BE).
Aaron P. Thrift, Alan G. Casson, Albanes, Anderson, Anna H. Wu, Baum, Brian J. Reid, Chow, Cook, Cook, Cook, Davey Smith, Davey Smith, Davey Smith, Davey Smith, David C. Whiteman, David M. Levine, Douglas A. Corley, Engeland, Geoffrey Liu, Green, Greenland, Harvey A. Risch, Hoyo, Hwang, Jacobson, Kabat, Kabat, Kubo, Lagergren, Lagergren, Laura J. Hardie, Lawlor, Leoncini, Leslie Bernstein, Levine, Liao, Lynn Onstad, Marilie D. Gammon, Nicholas J. Shaheen, Nigel C. Bird, O'Doherty, Palmer, Rubenstein, Staiger, Stein, Thomas L. Vaughan, Thrift, Thrift, Thrift, Thrift, Walter, Weimin Ye, Whiteman, Wong–Ho Chow, Yvonne Romero   +55 more
core   +2 more sources

Impact of Obesity on a Chinese Population with Erosive Esophagitis and Barrett’s Esophagus

Gut and Liver, 2017
Background/AimsThe aim of this study was to investigate the associations between obesity and erosive esophagitis (EE) or Barrett’s esophagus (BE) in a Chinese population.Methods : Data from subjects were retrospectively collected from 2006 to 2009 ...
Shou-Wu Lee, Han-Chung Lien, Teng-Yu Lee, Chun-Fang Tung, Hong-Zen Yeh, Chi-Sen Chang   +5 more
doaj   +1 more source

Evaluating Cost‐Effectiveness of 85 Endoscopic Surveillance Strategies of Nondysplastic Barrett's Esophagus

Journal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background Barrett's esophagus is the known precursor to esophageal adenocarcinoma (EAC), a cancer with poor prognosis. While endoscopic surveillance detects early dysplasia and prevents progression, most Barrett's esophagus patients do not progress to EAC, leading to invasive and costly surveillance.
Ravi Vissapragada, Norma B. Bulamu, Roger Yazbeck, Tomonori Aoki, Tim Bright, David I. Watson, Jonathan Karnon   +6 more
wiley   +1 more source

Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the International BEACON Consortium [PDF]

, 2010
BackgroundPrevious studies that showed an association between smoking and adenocarcinomas of the esophagus and esophagogastric junction were limited in their ability to assess differences by tumor site, sex, dose–response, and duration of cigarette ...
Abnet, C.C., Bernstein, L., Brown, L.M., Casson, A.G., Chow, W.H., Cook, M.B., Corley, D.A., Freedman, N.D., Gammon, M.D., Giffen, C., Kamangar, F., Linda, Sharpe, Murray, Liam, Nyren, O., Pandeya, N., Risch, H.A., Vaughan, T.L., Ward, M.H., Webb, P.M., Whiteman, D.C., Wu, P.M., Ye, W.   +21 more
core   +1 more source

Diagnosis and Management of Barrett’s Esophagus, Dysplasia and Early Esophageal Adenocarcinoma: Focusing on American and European Guidelines

The Korean Journal of Gastroenterology, 2019
Barrett’s esophagus (BE) is one of the most prominent diseases in Western countries because of its potential to progress to dysplasia or adenocarcinoma. Recently, the American College of Gastroenterology (ACG), American Gastroenterology Association (AGA),
Ah Young Yoo, Moon Kyung Joo
doaj   +1 more source

The Milan Score is an Effective Manometric Tool to Predict Gastroesophageal Reflux in Patients With Laryngopharyngeal Symptoms

Neurogastroenterology &Motility, EarlyView.
Patients with isolated LPS demonstrated a lower likelihood of EGJ disruption, pathologic GERD, and abnormal Milan score. The Milan score performed similarly well in the identification of GERD in both LPS and typical symptoms. The Milan score could therefore be used as an upfront test in LPS patients.
Stefano Siboni, Marco Sozzi, Pierfrancesco Visaggi, Ivan Kristo, Nicola De Bortoli, Salvatore Tolone, Elisa Marabotto, Daniele Bernardi, Sebastian F. Schoppmann, Roberto Penagini, Benjamin Rogers, Anthony Hobson, Jordan Haworth, Brian Louie, Yeong Yeh Lee, Vincent Tee, Takahiro Masuda, Dimitrios Theodorou, Tania Triantafyllou, Benedetta Barcella, Lorenzo Cusmai, Michele Puricelli, Marina Coletta, Vito Annese, Edoardo Vincenzo Savarino, Emanuele Luigi Giuseppe Asti, C. Prakash Gyawali   +26 more
wiley   +1 more source

O critério de positividade para a análise imunoistoquímica da p53 na confirmação da displasia do esôfago de Barrett faz diferença? Does positive criterium for p53 immunohistochemical analysis in the confirmation of Barrett's dysplasia make difference?

Arquivos de Gastroenterologia, 2005
RACIONAL: O esôfago de Barrett é uma complicação da doença do refluxo gastroesofágico com importante potencial de malignização. Relata-se que a expressão do marcador tumoral p53 se acentua com a progressão displasia-adenocarcinoma.
César Vivian Lopes, Júlio C. Pereira-Lima, Antônio Atalíbio Hartmann, Eunice Tonelotto, Karina Salgado   +4 more
doaj   +1 more source

Clinical backgrounds and outcomes of patients with Barrett's esophageal adenocarcinoma treated via endoscopic submucosal dissection in Kyushu, Japan: A retrospective multicenter cohort study

DEN Open, Volume 6, Issue 1, April 2026.
Abstract Objectives Most esophageal cancers in Japan are squamous cell carcinomas; however, there has been some concern regarding a recent increase in Barrett's esophageal adenocarcinoma (BEA). This study aimed to clarify the clinical characteristics and outcomes of patients treated via endoscopic submucosal dissection (ESD) in Kyushu, including ...
Fumisato Sasaki, Kazuhiro Mizukami, Taro Akashi, Naoyuki Yamaguchi, Ryosuke Gushima, Hideaki Miyamoto, Shohei Uehara, Yoichiro Ono, Takashi Hisabe, Yuzuru Kinjo, Yuichiro Nasu, Kensuke Fukuda, Taisuke Inada, Yorinobu Sumida, Takashi Akutagawa, Tadashi Miike, Sho Suzuki, Hiroki Fukuya, Michita Mukasa, Mitsuru Esaki, Shinsuke Kumei, Yosuke Minoda, Tetsu Kinjo, Daisuke Yamaguchi, Yoshio Fukuda, Kazutoshi Hashiguchi, Hiroki Yano, Hiroshi Fujita, Ryo Shimoda, GI‐Kysuhu study group   +29 more
wiley   +1 more source

Assessing the effectiveness of texture and color enhancement imaging versus white‐light endoscopy in detecting gastrointestinal lesions: A systematic review and meta‐analysis

DEN Open, Volume 6, Issue 1, April 2026.
Abstract Introduction Gastrointestinal cancers account for 26% of cancer incidence and 35% of cancer‐related deaths globally. Early detection is crucial but often limited by white light endoscopy (WLE), which misses subtle lesions. Texture and color enhancement imaging (TXI), introduced in 2020, enhances texture, brightness, and color, addressing WLE's
Muhammad Shahzil, Talha Bin Kashif, Zainab Jamil, Muhammad Ali Khaqan, Luqman Munir, Zunaira Amjad, Muhammad Saad Faisal, Ammad Javaid Chaudhary, Hassam Ali, Shahryar Khan, Ikponmwosa Enofe   +10 more
wiley   +1 more source

Wnt/beta-catenin/Tcf signaling: A critical pathway in gastrointestinal tumorigenesis [PDF]

, 2002
Cancers of the gastrointestinal tract, including the liver, bile ducts, and pancreas, constitute the largest group of malignant tumors. Colorectal cancer is one of the most common neoplastic diseases in Western countries and one of the leading causes of ...
Bommer, G., Göke, B., Kolligs, F. T.
core   +2 more sources